Multiplex Assay Kit for Ferritin, Heavy Polypeptide (FTH) ,etc. by FLIA (Flow Luminescence Immunoassay)

FTH1; FTHL6; PIG15; PLIF; Ferritin Heavy Chain; Apoferritin; Placenta Immunoregulatory Factor; Proliferation-Inducing Protein 15; Cell proliferation-inducing gene 15 protein

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Ferritin, Heavy Polypeptide (FTH) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Ferritin, Heavy Polypeptide (FTH) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Ferritin, Heavy Polypeptide (FTH) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Ferritin, Heavy Polypeptide (FTH) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 78-89 80
EDTA plasma(n=5) 83-103 88
heparin plasma(n=5) 97-105 101

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Ferritin, Heavy Polypeptide (FTH) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Ferritin, Heavy Polypeptide (FTH) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Ferritin, Heavy Polypeptide (FTH) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 81-93% 84-102% 87-103% 92-105%
EDTA plasma(n=5) 83-98% 84-98% 89-99% 96-103%
heparin plasma(n=5) 80-94% 83-101% 88-97% 89-96%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:FTH) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
PLoS One Presence in the Pre-Surgical Fine-Needle Aspiration of Potential Thyroid Biomarkers Previously Identified in the Post-Surgical One PubMed: PMC3765839
Am J Physiol Lung Cell Mol Physiol. Methemoglobin-induced signaling and chemokine responses in human alveolar epithelial cells Pubmed:24142518
J Alzheimers Dis The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer’s Disease PubMed: 26484920
Eur Radiol MR molecular imaging of tumours using ferritin heavy chain reporter gene expression mediated by the hTERT promoter Pubmed:26960542
Exp Hematol. Impact of TET2 deficiency on iron metabolism in erythroblasts. pubmed:28167288
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPD021Hu01 Recombinant Ferritin, Heavy Polypeptide (FTH) Positive Control; Immunogen; SDS-PAGE; WB.
PAD021Hu01 Polyclonal Antibody to Ferritin, Heavy Polypeptide (FTH) WB; IHC; ICC/IF
MAD021Hu23 Monoclonal Antibody to Ferritin, Heavy Polypeptide (FTH) WB; IHC; ICC; IP.
MAD021Hu22 Monoclonal Antibody to Ferritin, Heavy Polypeptide (FTH) WB; IHC; ICC; IP.
MAD021Hu21 Monoclonal Antibody to Ferritin, Heavy Polypeptide (FTH) WB; IHC
MAD021Hu24 Monoclonal Antibody to Ferritin, Heavy Polypeptide (FTH) WB; IHC; ICC; IP.
SED021Hu ELISA Kit for Ferritin, Heavy Polypeptide (FTH) Enzyme-linked immunosorbent assay for Antigen Detection.
LMD021Hu Multiplex Assay Kit for Ferritin, Heavy Polypeptide (FTH) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
PGD021Hu01 Primer Pair for Ferritin, Heavy Polypeptide (FTH) PCR